Everything Investors Need to Know About Coronavirus Tests
With the coronavirus pandemic showing no signs of stopping, public health officials everywhere agree that testing is critical to slowing the spread. Nearly 100 million diagnostic tests have been administered in the U.S. alone, where major diagnostic laboratories charge around $100 per assay. Producing enough tests to serve the world's dire need is a constant challenge, and countless corporations have stepped up to pitch in. Amid the rush to manufacture tests at massive scale, companies are also competing to offer diagnostics with the features that clinicians want the most.
Between the ever-expanding selection of testing products, manufacturers, and regulatory authorizations, it's easy to see how investors might get lost in the details. Read on and you'll soon have the background you need to intelligently consider the coronavirus diagnostics market.
Image source: Getty Images.
Source Fool.com
